Keener Financial Planning LLC Increases Position in Johnson & Johnson (NYSE:JNJ) by 42.1%
Are you looking to invest in a stable and reliable company? Look no further than Johnson & Johnson (NYSE:JNJ). This healthcare giant has been a favorite among investors for its consistent performance and strong financials. And it seems like institutional investors are taking notice too, with Keener Financial Planning LLC increasing its position in the company by a whopping 42.1% in the first quarter.
But Keener Financial Planning LLC isn’t the only one bullish on JNJ. WealthPLAN Partners LLC, Pacifica Partners Inc., Valued Wealth Advisors LLC, Walker Asset Management LLC, and Tompkins Financial Corp have all either added to or reduced their stakes in the company. With hedge funds and other institutional investors owning a significant portion of JNJ’s stock, it’s clear that confidence in this company runs deep.
And it’s not just institutional investors who are singing JNJ’s praises. Analysts have been quick to weigh in on the stock, with several brokerages giving it positive ratings and price targets. From Cantor Fitzgerald to HSBC, the consensus seems to be that JNJ is a solid buy with strong potential for growth.
In terms of performance, JNJ has been holding steady, with its stock up 0.1% and a market capitalization of $360.71 billion. The company recently reported earnings that beat analyst estimates, further solidifying its position as a top performer in the healthcare industry.
But perhaps the most enticing news for investors is JNJ’s recent dividend increase. With a quarterly dividend of $1.24 per share and a dividend yield of 3.31%, JNJ is not only a stable investment but also a lucrative one.
So, if you’re looking for a reliable company with strong financials, consistent performance, and a promising future, look no further than Johnson & Johnson. With the backing of institutional investors, positive analyst ratings, and a solid dividend, JNJ is a stock worth considering for your portfolio.